APOE-ε4 modulates the association between regional amyloid deposition and cognitive performance in cognitively unimpaired middle-aged individuals.
Anna Brugulat-SerratGonzalo Sánchez-BenavidesRaffaele CacciagliaGemma SalvadóMahnaz ShekariLyduine E CollijChristopher BuckleyBart N M van BerckelAndrés PerissinottiAida Niñerola-BaizánMarta Milà-AlomàNatàlia Vilor-TejedorGrégory OpertoCarles FalconOriol Grau-RiveraEider M Arenaza-UrquijoCarolina MinguillónKarine FauriaJosé Luis MolinuevoMarc Suárez-CalvetJuan-Domingo Gispertnull nullPublished in: EJNMMI research (2023)
gov Identifier: NCT02485730. Registered 20 June 2015 https://clinicaltrials.gov/ct2/show/NCT02485730 and ClinicalTrials.gov Identifier:NCT02685969. Registered 19 February 2016 https://clinicaltrials.gov/ct2/show/NCT02685969 .